Details for New Drug Application (NDA): 020364

✉ Email this page to a colleague

NDA 020364 describes LOTREL, which is a drug marketed by Sandoz and is included in one NDA. It is available from one supplier. Additional details are available on the LOTREL profile page.

The generic ingredient in LOTREL is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

Summary for 020364

Tradename:	LOTREL
Applicant:	Sandoz
Ingredient:	amlodipine besylate; benazepril hydrochloride
Patents:	0

Pharmacology for NDA: 020364

Mechanism of Action	Angiotensin-converting Enzyme Inhibitors Calcium Channel Antagonists Cytochrome P450 3A Inhibitors
Physiological Effect	Decreased Blood Pressure

Suppliers and Packaging for NDA: 020364

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364	NDA	Novartis Pharmaceuticals Corporation	0078-0364	0078-0364-05	100 CAPSULE in 1 BOTTLE (0078-0364-05)
LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364	NDA	Novartis Pharmaceuticals Corporation	0078-0379	0078-0379-05	100 CAPSULE in 1 BOTTLE (0078-0379-05)

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 2.5MG BASE;10MG
Approval Date:	Mar 3, 1995	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 5MG BASE;10MG
Approval Date:	Mar 3, 1995	TE:	AB	RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 5MG BASE;20MG
Approval Date:	Mar 3, 1995	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020364

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sandoz	LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364-004	Mar 3, 1995	4,572,909	⤷ Subscribe
Sandoz	LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364-005	Jun 20, 2002	4,879,303	⤷ Subscribe
Sandoz	LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364-007	Apr 11, 2006	6,162,802	⤷ Subscribe
Sandoz	LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364-003	Mar 3, 1995	4,410,520*PED	⤷ Subscribe
Sandoz	LOTREL	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	020364-004	Mar 3, 1995	4,410,520*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.